Transforming Growth Factor β-Independent Shuttling of Smad4 between the Cytoplasm and Nucleus

ABSTRACT Smad4 plays a pivotal role in all transforming growth factor β (TGF-β) signaling pathways. Here we describe six widely expressed alternatively spliced variants of human Smad4 with deletions of different exons in the linker, the region of Smad4 that separates the two well-conserved MH1 and MH2 domains. All these Smad4 variants form complexes with activated Smad2 and Smad3 and are incorporated into DNA-binding complexes with the transcription factor Fast-1, regardless of the amount of linker they contain. However, sequences encoded by exons 5 to 7 in the linker are essential for transcriptional activation. Most importantly, our observation that different Smad4 isoforms have different subcellular localizations has led us to the identification of a functional CRM1-dependent nuclear export signal in the Smad4 linker and a constitutively active nuclear localization signal in the N-terminal MH1 domain. In the absence of TGF-β signaling, we conclude that Smad4 is rapidly and continuously shuttling between the nucleus and the cytoplasm, the distribution of Smad4 between the nucleus and the cytoplasm being dictated by the relative strengths of the nuclear import and export signals. We demonstrate that inhibition of CRM1-mediated nuclear export by treatment of cells with leptomycin B results in endogenous Smad4 accumulating very rapidly in the nucleus. Endogenous Smad2 and Smad3 are completely unaffected by leptomycin B treatment, indicating that the nucleocytoplasmic shuttling is specific for Smad4. We propose that, upon TGF-β signaling, complex formation between Smad4 and activated Smad2 or -3 leads to nuclear accumulation of Smad4 through inhibition of its nuclear export. We demonstrate that after prolonged TGF-β signaling Smad2 becomes dephosphorylated and Smad2 and Smad4 accumulate back in the cytoplasm.

[1]  C. Heldin,et al.  Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts as a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible Enhancer* , 1998, The Journal of Biological Chemistry.

[2]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[3]  J. Massagué,et al.  Ubiquitin-dependent degradation of TGF-β-activated Smad2 , 1999, Nature Cell Biology.

[4]  D. Fujiwara,et al.  Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. , 1994, The Journal of biological chemistry.

[5]  F. van Roy,et al.  Nuclear localization of the p120(ctn) Armadillo-like catenin is counteracted by a nuclear export signal and by E-cadherin expression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Takeshi Imamura,et al.  TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4 , 1997 .

[7]  J. Massagué,et al.  Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4 , 1997, Nature.

[8]  S. Tsukita,et al.  Cortical Actin Organization: Lessons from ERM (Ezrin/Radixin/Moesin) Proteins* , 1999, The Journal of Biological Chemistry.

[9]  J. Massagué TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[10]  R. Laskey,et al.  Nuclear targeting sequences--a consensus? , 1991, Trends in biochemical sciences.

[11]  S. Germain,et al.  Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif. , 2000, Genes & development.

[12]  J. Massagué,et al.  TGF- SIGNAL TRANSDUCTION , 1998 .

[13]  Smads and early developmental signaling by the TGFbeta superfamily. , 1998, Genes & development.

[14]  C. Heldin,et al.  SMAD destruction turns off signalling , 1999, Nature Cell Biology.

[15]  Liliana Attisano,et al.  SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor , 1998, Cell.

[16]  Erich A. Nigg,et al.  Nucleocytoplasmic transport: signals, mechanisms and regulation , 1997, Nature.

[17]  J. Massagué,et al.  Transcriptional control by the TGF‐β/Smad signaling system , 2000 .

[18]  R. Treisman,et al.  The Rho family GTPases RhoA, Racl , and CDC42Hsregulate transcriptional activation by SRF , 1995, Cell.

[19]  Minoru Watanabe,et al.  Smad4 and FAST-1 in the assembly of activin-responsive factor , 1997, Nature.

[20]  T. Shioda,et al.  The Smad4 Activation Domain (SAD) Is a Proline-rich, p300-dependent Transcriptional Activation Domain* , 2000, The Journal of Biological Chemistry.

[21]  N. Seki,et al.  DPC4 splice variants in neuroblastoma. , 1998, Cancer letters.

[22]  U. Kutay,et al.  Transport between the cell nucleus and the cytoplasm. , 1999, Annual review of cell and developmental biology.

[23]  한평림 A Transcriptional Partner for MAD Proteins in TGF - b Signalling , 1996 .

[24]  R. Weinberg,et al.  SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  K. Luo,et al.  Negative Feedback Regulation of TGF-β Signaling by the SnoN Oncoprotein , 1999 .

[26]  Philip A Beachy,et al.  Nuclear Trafficking of Cubitus interruptus in the Transcriptional Regulation of Hedgehog Target Gene Expression , 1999, Cell.

[27]  J. Massagué,et al.  A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. , 1999, Genes & development.

[28]  K. Miyazono,et al.  Signaling inputs converge on nuclear effectors in TGF-β signaling , 2000 .

[29]  P. Dijke,et al.  DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumour cells , 1997, Oncogene.

[30]  Xin Chen,et al.  A transcriptional partner for MAD proteins in TGF-β signalling , 1996, Nature.

[31]  T. Maniatis,et al.  Activation of the human beta-interferon gene requires an interferon-inducible factor , 1986, Molecular and cellular biology.

[32]  A. Roberts,et al.  Characterization of Functional Domains within Smad4/DPC4* , 1997, The Journal of Biological Chemistry.

[33]  O. Madsen,et al.  mRNA Profiling of Rat Islet Tumors Reveals Nkx 6.1 as a β-Cell-specific Homeodomain Transcription Factor* , 1996, The Journal of Biological Chemistry.

[34]  M. Whitman Smads and early developmental signaling by the TGFbeta superfamily. , 1998, Genes & development.

[35]  M. Kretzschmar,et al.  Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1 , 1997, Nature.

[36]  J. Massagué,et al.  Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes. , 1997, Genes & development.

[37]  E. O’Shea,et al.  Regulation of nuclear localization: a key to a door. , 1999, Annual review of cell and developmental biology.

[38]  Jian-ming Li,et al.  Smad3-Smad4 and AP-1 Complexes Synergize in Transcriptional Activation of the c-Jun Promoter by Transforming Growth Factor β , 1999, Molecular and Cellular Biology.

[39]  J. Massagué,et al.  GS domain mutations that constitutively activate T beta R‐I, the downstream signaling component in the TGF‐beta receptor complex. , 1995, The EMBO journal.

[40]  S. Valgeirsdóttir,et al.  Xenopus Smad4beta is the co-Smad component of developmentally regulated transcription factor complexes responsible for induction of early mesodermal genes. , 1999, Developmental biology.

[41]  P. D. Vize,et al.  Identification of a potential regulator of early transcriptional responses to mesoderm inducers in the frog embryo. , 1995, The EMBO journal.

[42]  H. Lodish,et al.  Importin β Mediates Nuclear Translocation of Smad 3* , 2000, The Journal of Biological Chemistry.

[43]  Richard Treisman,et al.  Signal-Regulated Activation of Serum Response Factor Is Mediated by Changes in Actin Dynamics , 1999, Cell.

[44]  J. Massagué,et al.  OAZ Uses Distinct DNA- and Protein-Binding Zinc Fingers in Separate BMP-Smad and Olf Signaling Pathways , 2000, Cell.

[45]  T. Hope,et al.  An N‐terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IκBα , 1999 .

[46]  八木 健,et al.  Alternatively spliced variant of smad2 lacking exon 3 : comparison with wild-type smad2 and smad3 , 2001 .

[47]  R. Flavell,et al.  Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease , 2000 .

[48]  Jian-ming Li,et al.  Smad 3-Smad 4 and AP-1 Complexes Synergize in Transcriptional Activation of the c-Jun Promoter by Transforming Growth Factor b , 1999 .

[49]  G. Ruvkun,et al.  The DAF-3 Smad protein antagonizes TGF-beta-related receptor signaling in the Caenorhabditis elegans dauer pathway. , 1997, Genes & development.

[50]  R. Derynck,et al.  Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4 , 1997, Molecular and cellular biology.

[51]  Kathleen R. Cho,et al.  DPC4 gene in various tumor types. , 1996, Cancer research.

[52]  Jeffrey L. Wrana,et al.  A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation , 1999, Nature.

[53]  Xin-Hua Feng,et al.  Microtubule Binding to Smads May Regulate TGFβ Activity , 2000 .

[54]  E. Nishida,et al.  Identification of Two Smad4 Proteins in Xenopus , 1999, The Journal of Biological Chemistry.